The effectiveness unlocks immediate selling by insiders and private placement investors. Expect downward pressure on HKPD as shares hit the market. Monitor trading volume and any subsequent Form 4 filings for insider sales. The controlled company structure (95.63% voting power held by Ms. Liying Wang) limits governance checks on selling.
Price Chart
Executive Summary
Cellyan Biotechnology's resale registration statement (F-1) became effective on June 24, 2026, allowing selling shareholders to resell up to 12,499,986 Class A ordinary shares into the market. The company receives no proceeds from these sales, but the registration creates a significant overhang of shares that could be sold, representing roughly half of the company's market cap at recent prices.
Key Facts
- Registration statement (File No. 333-296754) declared effective on June 24, 2026.
- Up to 12,499,986 Class A ordinary shares registered for resale by selling shareholders.
- Shares were originally issued in a March 2026 private placement; company receives no proceeds.
- Last reported sale price on Nasdaq was $0.65 per share as of March 26, 2026.
- Market capitalization is approximately $16 million, making the registered shares a large portion of the float.
Financial Impact
Potential selling of up to 12.5M shares valued at ~$8.1M (based on $0.65 reference price), representing roughly 50% of current market cap.
Risk Factors
- Significant selling pressure from the 12.5M share overhang relative to a $16M market cap.
- Low liquidity could amplify price declines on any selling.
- Controlled company structure reduces shareholder protections and board independence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002111 |
| Document: 9999999995-26-002111-index.html | 9999999995-26-002111 |
| Document: 9999999995-26-002111.txt | 9999999995-26-002111 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 6-K | $0.1020 $0.0960 | ▲ +5.88% | ▲ +4.70% | $2.14 (−1998.04%) |
Sep 23, 2026 4w ago | 6-K | $0.1207 $0.1118 | ▼ −7.37% | ▼ −7.92% | $2.14 (+1672.99%) |
Sep 23, 2026 4w ago | 6-K | $0.1192 $0.1207 | ▲ +1.26% | ▲ +1.34% | $2.14 (+1695.30%) |
Jun 25, 2026 17w ago | EFFECT | $0.3710 $0.3610 | ▲ +2.70% | ▲ +1.97% | $2.14 (−476.82%) |
Apr 9, 2026 28w ago | EFFECT | $0.5570 $0.6220 | ▲ +11.67% | ▲ +11.73% | $2.14 (+284.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers